ArticleAmerican journal of cancer research2025
The predictive value of contrast-enhanced ultrasound parameters combined with inflammatory nutritional indicators for recurrence and survival of early liver cancer following radiofrequency ablation.
Article in American journal of cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to explore the predictive value of contrast-enhanced ultrasound (CEUS) parameters combined with inflammatory-nutritional indices for recurrence and survival following radiofrequency ablation (RFA) in early-stage hepatocellular carcinoma (HCC). It also sought to provide evidence-based personalized treatment strategies for clinical practice. A retrospective analysis was conducted on the clinical data of 263 HCC patients who underwent RFA at Henan Provincial People's Hospital from January 2021 to June 2022. Comprehensive data on tumor angiogenesis and hemodynamics were collected using CEUS, and the Prognostic Inflammatory and Nutritional Index (PINI) was calculated. Multivariate Cox analysis was performed to assess the predictive efficacy of these parameters for tumor recurrence and long-term survival. The study found that a low PINI score was associated with a higher risk of postoperative tumor recurrence and mortality. Among the CEUS parameters, time to peak, peak intensity, enhancement rate, and PINI were significantly correlated with tumor recurrence and patient survival. The combined scoring system, integrating CEUS parameters and PINI (CEUS-PINI), effectively distinguished different risk groups and was significantly associated with both recurrence-free survival and overall survival. In conclusion, the combination of CEUS parameters and PINI provides a simple, non-invasive prognostic tool that helps predict recurrence risk and survival outcomes following RFA in early-stage HCC. This combined assessment system can aid in the early identification of high-risk patients and facilitate the development of postoperative monitoring and management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.